Suppr超能文献

用于增强抗癌疗效的多功能线粒体靶向纳米系统

Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer Efficacy.

作者信息

Hu Tingting, Qin Zhou, Shen Chao, Gong Han-Lin, He Zhi-Yao

机构信息

Department of Pharmacy, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.

Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Front Bioeng Biotechnol. 2021 Nov 24;9:786621. doi: 10.3389/fbioe.2021.786621. eCollection 2021.

Abstract

Mitochondria, a kind of subcellular organelle, play crucial roles in cancer cells as an energy source and as a generator of reactive substrates, which concern the generation, proliferation, drug resistance, and other functions of cancer. Therefore, precise delivery of anticancer agents to mitochondria can be a novel strategy for enhanced cancer treatment. Mitochondria have a four-layer structure with a high negative potential, which thereby prevents many molecules from reaching the mitochondria. Luckily, the advances in nanosystems have provided enormous hope to overcome this challenge. These nanosystems include liposomes, nanoparticles, and nanomicelles. Here, we summarize the very latest developments in mitochondria-targeting nanomedicines in cancer treatment as well as focus on designing multifunctional mitochondria-targeting nanosystems based on the latest nanotechnology.

摘要

线粒体是一种亚细胞器,在癌细胞中作为能量来源和反应性底物的产生者发挥着关键作用,这涉及到癌症的发生、增殖、耐药性及其他功能。因此,将抗癌药物精确递送至线粒体可能是一种增强癌症治疗效果的新策略。线粒体具有四层结构且电势高度为负,这使得许多分子难以进入线粒体。幸运的是,纳米系统的进展为克服这一挑战带来了巨大希望。这些纳米系统包括脂质体、纳米颗粒和纳米胶束。在此,我们总结了线粒体靶向纳米药物在癌症治疗方面的最新进展,并重点关注基于最新纳米技术设计多功能线粒体靶向纳米系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/8652136/70b3aa033e08/fbioe-09-786621-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验